- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 46.07M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 7.43M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$5.68M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$12.42M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $85.62M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $81M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $13.85M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $18.7M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$142.7M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$172.81M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $226.01M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $257.54M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $333.27M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $362.26M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $155.89M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $179.39M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $198.33M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $223.29M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.33 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.41 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.33 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.41 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $13.09M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $18.19M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $6.63M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $7.44M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$17.15M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$9.45M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$13.67M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$2.21M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $154.4M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $170.7M |
| Revenue | Q1 2024 · Mar 31, 2024 | $163.06M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $179.06M |